Biocinese   Report issue

For profit Phase 4
Founded: Toledo Brazil (2005)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
2008
NCT01367054
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

sitagliptin (januvia) (2 trials)

tamsulosin (flomax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperplasia (Phase 4)

Polycystic Ovary Syndrome (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 2